Medtronic price target raised to $93 from $89 at Truist
Truist raised the firm’s price target on Medtronic (MDT) to $93 from $89 and keeps a Hold rating on the shares after its Q3 earnings beat. Despite the organic revenue miss, Medtronic saw ...
MarketBeat on MSN14h
Medtronic's Expansion Gains Momentum-Time for a Market Shift?
Medtronic’s (NYSE: MDT) growth efforts and investments in medical technology innovation are starting to pay off. The ...
CeriBell: A Leader In AI-Powered Seizure Detection
CeriBell's AI-powered EEG system offers rapid seizure diagnosis. The stock is undervalued by at least 50% over the long-term, ...
Investor's Business Daily on MSN12h
Stock Market Indexes Dip, Growth Struggles; Palantir, Axon, Alibaba In Focus: Weekly Review
T he stock market had some highs and lows. The S&P 500 hit a record high, but pared modestly weekly gains. The Nasdaq was ...
Is Medtronic Stock a Buy?
Medtronic's stock is probably not a jaw-dropping bargain at these prices, but it's an excellent business at a reasonable value. It's safe to call Medtronic a solid buy, especially if you're a ...